Literature DB >> 10759775

Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages.

L Overbergh1, B Decallonne, D Valckx, A Verstuyf, J Depovere, J Laureys, O Rutgeerts, R Saint-Arnaud, R Bouillon, C Mathieu.   

Abstract

Receptors for 1,25(OH)2vitaminD3 are found in most immune cells and important immunological effects have been described in vitro, reflected by its capacity to prevent autoimmunity and to prolong graft survival. The aim of this study was to examine the presence and nature of the enzyme responsible for final activation of the molecule, 1-alpha-hydroxylase, in murine macrophages and to analyse its regulation and possible role in the immune system. Peritoneal macrophages from C57Bl/6 mice were incubated with lipopolysaccharide (LPS; 100 microg/ml), interferon-gamma (IFN-gamma; 500 U/ml) or a combination of both. By quantitative reverse transcriptase-polymerase chain reaction, using primers based on the murine renal cDNA sequence, low levels of 1-alpha-hydroxylase mRNA were detected in freshly isolated cells (18 +/- 7 x 10-6 copies/beta-actin copies). Analysis of the cDNA sequence of the gene revealed identical coding sequences for the macrophage and renal enzymes. mRNA levels rose three-fold with LPS (NS), but a six-fold increase was seen after IFN-gamma stimulation (P < 0.05). Combining LPS and IFN-gamma did not result in a major additional increase, but addition of cyclosporin A further increased levels 2.5-fold both in IFN-gamma- and combination-stimulated cells (P < 0.05). Time course analysis revealed that up-regulation of 1-alpha-hydroxylase was a late phenomenon, preceded by the up-regulation of activating macrophage products such as IL-1 and tumour necrosis factor-alpha. Finally, a defect in 1-alpha-hydroxylase up-regulation by immune stimuli was found in autoimmune non-obese diabetic mice. In conclusion, we propose that the up-regulation of 1-alpha-hydroxylase in activated macrophages, resulting in the synthesis of 1,25(OH)2D3, might be a negative feedback loop in inflammation. A defect in this system might be an additional element in tipping the balance towards autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10759775      PMCID: PMC1905630          DOI: 10.1046/j.1365-2249.2000.01204.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  35 in total

1.  Nuclear factor of activated T cells (NFAT) as a molecular target for 1alpha,25-dihydroxyvitamin D3-mediated effects.

Authors:  A Takeuchi; G S Reddy; T Kobayashi; T Okano; J Park; S Sharma
Journal:  J Immunol       Date:  1998-01-01       Impact factor: 5.422

2.  Molecular cloning of cDNA and genomic DNA for human 25-hydroxyvitamin D3 1 alpha-hydroxylase.

Authors:  T Monkawa; T Yoshida; S Wakino; T Shinki; H Anazawa; H F Deluca; T Suda; M Hayashi; T Saruta
Journal:  Biochem Biophys Res Commun       Date:  1997-10-20       Impact factor: 3.575

3.  Prevention of diabetes recurrence after syngeneic islet transplantation in NOD mice by analogues of 1,25(OH)2D3 in combination with cyclosporin A: mechanism of action involves an immune shift from Th1 to Th2.

Authors:  C Mathieu; K Casteels; M Waer; J Laureys; D Valckx; R Bouillon
Journal:  Transplant Proc       Date:  1998-03       Impact factor: 1.066

4.  25-Hydroxyvitamin D3 1alpha-hydroxylase and vitamin D synthesis.

Authors:  K Takeyama; S Kitanaka; T Sato; M Kobori; J Yanagisawa; S Kato
Journal:  Science       Date:  1997-09-19       Impact factor: 47.728

5.  gamma-Interferon-induced resistance to 1,25-(OH)2 D3 in human monocytes and macrophages: a mechanism for the hypercalcemia of various granulomatoses.

Authors:  A S Dusso; S Kamimura; M Gallieni; M Zhong; L Negrea; S Shapiro; E Slatopolsky
Journal:  J Clin Endocrinol Metab       Date:  1997-07       Impact factor: 5.958

6.  Cloning of human 25-hydroxyvitamin D-1 alpha-hydroxylase and mutations causing vitamin D-dependent rickets type 1.

Authors:  G K Fu; D Lin; M Y Zhang; D D Bikle; C H Shackleton; W L Miller; A A Portale
Journal:  Mol Endocrinol       Date:  1997-12

7.  Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene.

Authors:  D D'Ambrosio; M Cippitelli; M G Cocciolo; D Mazzeo; P Di Lucia; R Lang; F Sinigaglia; P Panina-Bordignon
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

8.  Prevention of type I diabetes in nonobese diabetic mice by late intervention with nonhypercalcemic analogs of 1,25-dihydroxyvitamin D3 in combination with a short induction course of cyclosporin A.

Authors:  K M Casteels; C Mathieu; M Waer; D Valckx; L Overbergh; J M Laureys; R Bouillon
Journal:  Endocrinology       Date:  1998-01       Impact factor: 4.736

9.  The 25-hydroxyvitamin D 1-alpha-hydroxylase gene maps to the pseudovitamin D-deficiency rickets (PDDR) disease locus.

Authors:  R St-Arnaud; S Messerlian; J M Moir; J L Omdahl; F H Glorieux
Journal:  J Bone Miner Res       Date:  1997-10       Impact factor: 6.741

10.  Autoregulation of 1,25-dihydroxyvitamin D synthesis in macrophage mitochondria by nitric oxide.

Authors:  J S Adams; S Y Ren
Journal:  Endocrinology       Date:  1996-10       Impact factor: 4.736

View more
  60 in total

1.  Is plasma 25(OH) D related to adipokines, inflammatory cytokines and insulin resistance in both a healthy and morbidly obese population?

Authors:  Núria Vilarrasa; Joan Vendrell; Javier Maravall; Iñaki Elío; Esther Solano; Patricia San José; Isabel García; Núria Virgili; Juan Soler; José Manuel Gómez
Journal:  Endocrine       Date:  2010-07-23       Impact factor: 3.633

Review 2.  Vitamin D signaling, infectious diseases, and regulation of innate immunity.

Authors:  John H White
Journal:  Infect Immun       Date:  2008-05-27       Impact factor: 3.441

3.  Association of 1.25 vitamin D3 deficiency, disease activity and low bone mass in ankylosing spondylitis.

Authors:  U Lange; J Teichmann; J Strunk; U Müller-Ladner; K L Schmidt
Journal:  Osteoporos Int       Date:  2005-09-20       Impact factor: 4.507

Review 4.  Bone: a key aspect to understand phenomena in clinical hematology.

Authors:  Kanako Wakahashi; Yoshio Katayama
Journal:  J Bone Miner Metab       Date:  2020-01-02       Impact factor: 2.626

Review 5.  Vitamin D insufficiency: implications for the immune system.

Authors:  Femke Baeke; Conny Gysemans; Hannelie Korf; Chantal Mathieu
Journal:  Pediatr Nephrol       Date:  2010-02-24       Impact factor: 3.714

6.  Murine CD8+ T cells but not macrophages express the vitamin D 1α-hydroxylase.

Authors:  Jot Hui Ooi; Kaitlin L McDaniel; Veronika Weaver; Margherita T Cantorna
Journal:  J Nutr Biochem       Date:  2013-10-10       Impact factor: 6.048

7.  Nano-encapsulation of vitamin D3 active metabolites for application in chemotherapy: formulation study and in vitro evaluation.

Authors:  Eyad Almouazen; Sandrine Bourgeois; Lars Petter Jordheim; Hatem Fessi; Stephanie Briançon
Journal:  Pharm Res       Date:  2012-12-08       Impact factor: 4.200

Review 8.  Vitamin D and human health: lessons from vitamin D receptor null mice.

Authors:  Roger Bouillon; Geert Carmeliet; Lieve Verlinden; Evelyne van Etten; Annemieke Verstuyf; Hilary F Luderer; Liesbet Lieben; Chantal Mathieu; Marie Demay
Journal:  Endocr Rev       Date:  2008-08-11       Impact factor: 19.871

9.  Vitamin D inflammatory cytokines and coronary events: a comprehensive review.

Authors:  Yoav Arnson; Dganit Itzhaky; Morris Mosseri; Vivian Barak; Boaz Tzur; Nancy Agmon-Levin; Howard Amital
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

10.  Is vitamin D deficiency involved in the immune reconstitution inflammatory syndrome?

Authors:  Anali Conesa-Botella; Chantal Mathieu; Robert Colebunders; Rodrigo Moreno-Reyes; Evelyne van Etten; Lut Lynen; Luc Kestens
Journal:  AIDS Res Ther       Date:  2009-04-21       Impact factor: 2.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.